Background and purpose: Isocitrate dehydrogenase (IDH) wild-type lower-grade gliomas (histologic grades II and III) with epidermal growth factor receptor (EGFR) amplification or telomerase reverse transcriptase (TERT) promoter mutation are reported to behave similar to glioblastoma. We aimed to evaluate whether MR imaging features could identify a subset of IDH wild-type lower-grade gliomas that carry molecular features of glioblastoma. Materials and methods: In this multi-institutional retrospective study, pathologically confirmed IDH wild-type lower-grade gliomas from 2 tertiary institutions and The Cancer Genome Atlas constituted the training set (institution 1 and The Cancer Genome Atlas, 64 patients) and the independent test set (inst...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
BACKGROUND AND PURPOSE: Few studies have shown MR imaging features and ADC correlating with molecula...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
Background and purposeIsocitrate dehydrogenase (IDH) wild-type lower-grade gliomas (histologic grade...
Purpose: We predicted molecular profiles in newly diagnosed glioblastoma patients using magnetic res...
Purpose: To identify significant prognostic magnetic resonance imaging (MRI) features and their prog...
BACKGROUND AND PURPOSE: WHO grade II gliomas are divided into three classes: isocitrate dehydrogenas...
Glioblastomas (GBM) are the commonest and most aggressive primary tumour of the brain. They are asso...
To address the current lack of dynamic susceptibility contrast magnetic resonance imaging (DSC–MRI)-...
PURPOSE: To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improv...
Purpose: To investigate the associations of MRI radiological features and prognosis of glioma with t...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
BACKGROUND AND PURPOSE: Few studies have shown MR imaging features and ADC correlating with molecula...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
Background and purposeIsocitrate dehydrogenase (IDH) wild-type lower-grade gliomas (histologic grade...
Purpose: We predicted molecular profiles in newly diagnosed glioblastoma patients using magnetic res...
Purpose: To identify significant prognostic magnetic resonance imaging (MRI) features and their prog...
BACKGROUND AND PURPOSE: WHO grade II gliomas are divided into three classes: isocitrate dehydrogenas...
Glioblastomas (GBM) are the commonest and most aggressive primary tumour of the brain. They are asso...
To address the current lack of dynamic susceptibility contrast magnetic resonance imaging (DSC–MRI)-...
PURPOSE: To evaluate whether diffusion tensor imaging (DTI) radiomics with machine learning improv...
Purpose: To investigate the associations of MRI radiological features and prognosis of glioma with t...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
Purpose: The primary aim of this prospective observational study was to assess whether diffusion MRI...
BACKGROUND AND PURPOSE: Few studies have shown MR imaging features and ADC correlating with molecula...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...